STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Aurinia Pharmaceuticals Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

This Amendment No. 16 to the Schedule 13D reports the holdings and recent transactions by ILJIN-related reporting persons in Aurinia Pharmaceuticals Inc.'s common shares. Chin Kyu Huh beneficially owns 6,535,141 shares, equal to 5.0% of the outstanding class, and certain ILJIN entities report shared voting and dispositive power over 5,411,533 shares (4.1%). The filing states small purchases by family members and material secondary-market sales by ILJIN SNT and a family member, with per-share prices disclosed.

The filing also states the Reporting Persons may be deemed a group for Section 13(d)(3) purposes while disclaiming certain beneficial ownerships among family members and entities. All percentage calculations are based on 131,629,546 shares outstanding as reported by the issuer.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Disclosure shows a 5.0% individual stake and quantified secondary-market sales; transparency on holdings and transactions is material to investors.

The filing provides clear, itemized ownership amounts and transaction details. Chin Kyu Huh is reported as beneficial owner of 6,535,141 shares (5.0%), and ILJIN-related entities report shared power over 5,411,533 shares (4.1%). The reporting persons disclosed sales totaling 498,538 shares by ILJIN SNT and 108,000 shares by Seoung Eun Huh with per-share prices included, and small purchases by two family members. The ownership and transaction figures are based on the issuer's reported 131,629,546 outstanding shares, making these disclosures material to assessments of insider activity and potential voting influence.

TL;DR: The filing indicates potential coordinated ownership among ILJIN entities and family members and discloses a >5% beneficial holding, which is governance-relevant.

The statement notes the Reporting Persons "may be deemed" a group under Section 13(d)(3), while also disclaiming certain cross-family beneficial ownerships. A reported 5.0% stake by an individual stockholder is a threshold often considered significant for governance and proxy considerations. The filing's Amended and Restated Agreement of Joint Filing is listed as an exhibit, reinforcing formal coordination among the reporting persons for disclosure purposes.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


ILJIN SNT Co., Ltd.
Signature:/s/ Tae Wan Kim
Name/Title:Tae Wan Kim/Authorized Signatory
Date:08/13/2025
ILJIN Steel Co., Ltd.
Signature:/s/ Tae Wan Kim
Name/Title:Tae Wan Kim/Authorized Signatory
Date:08/13/2025
ILJIN GLS Co., Ltd.
Signature:/s/ Tae Wan Kim
Name/Title:Tae Wan Kim/Authorized Signatory
Date:08/13/2025
Sae Kyoung Huh
Signature:/s/ Sae Kyoung Huh
Name/Title:Sae Kyoung Huh
Date:08/13/2025
Seoung Eun Huh
Signature:/s/ Seoung Eun Huh
Name/Title:Seoung Eun Huh
Date:08/13/2025
Chin Kyu Huh
Signature:/s/ Chin Kyu Huh
Name/Title:Chin Kyu Huh
Date:08/13/2025

FAQ

How many Aurinia (AUPH) shares does Chin Kyu Huh own?

Chin Kyu Huh beneficially owns 6,535,141 shares, equal to 5.0% of the outstanding common shares based on 131,629,546 shares reported by the issuer.

What sales did ILJIN SNT report in the Schedule 13D/A for AUPH?

ILJIN SNT sold a total of 498,538 shares at reported per-share prices of $10.22, $11.28, $11.49 and $11.43 (itemized in the filing).

Did any family members buy or sell AUPH shares?

Sae Kyoung Huh purchased 3,600 shares for $22,594.70 and Seoung Eun Huh purchased 10,000 shares for $55,946 using cash on hand; Seoung Eun Huh also sold 108,000 shares at prices between $8.56 and $8.91.

Do the reporting persons act as a group for AUPH disclosures?

The filing states the Reporting Persons may be deemed a 'group' under Section 13(d)(3) but also notes the filing should not be construed as an admission that they are a group.

What ILJIN-related holdings are disclosed in the filing?

ILJIN SNT/ILJIN GLS report shared voting/dispositive power over 5,411,533 shares (4.1%); ILJIN Steel reports 1,123,608 shares (0.9%).
Aurinia Pharmace

NASDAQ:AUPH

AUPH Rankings

AUPH Latest News

AUPH Latest SEC Filings

AUPH Stock Data

2.04B
122.02M
7.15%
45.57%
6.78%
Biotechnology
Pharmaceutical Preparations
Link
Canada
EDMONTON